Hospira Vinorelbine Tartrate for Injection 50 mg/5 mL vial

Страна: Австралия

Язык: английский

Источник: Department of Health (Therapeutic Goods Administration)

Активный ингредиент:

vinorelbine tartrate, Quantity: 13.85 mg/mL

Доступна с:

Hospira Australia Pty Ltd

ИНН (Международная Имя):

Vinorelbine tartrate

Фармацевтическая форма:

Injection

состав:

Excipient Ingredients: water for injections

Администрация маршрут:

Intravenous

Штук в упаковке:

1 x 5 mL vial

класс:

Medicine Listed (Export Only)

Тип рецепта:

Not scheduled. Not considered by committee

Терапевтические показания :

Vinorelbine tartrate is indicated in the treatment of advanced non-small cell lung cancer (NSCLC), as a single agent or in combination. Vinorelbine tartrate is also indicated for the treatment of patients with metastatic breast cancer who have failed standard first-line chemotherapy for metastatic disease. In addition, vinorelbine tartrate is indicated for the treatment of patients with metastatic breast cancer who have relapsed within 6 months of anthracycline-based adjuvant therapy.

Обзор продуктов:

Visual Identification: A clear, colourless to pale yellow solution & free from visible particulates; Container Type: Vial; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius

Статус Авторизация:

Licence status A

Дата Авторизация:

2008-05-05